|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
4/30/2010 9:28:17 AM
BLUE BELL, Pa.--(BUSINESS WIRE)--Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today that its CEO, Dr. J. Joseph Kim, will present a corporate update on its DNA vaccines for influenza, HIV and cancer and its vaccine delivery technology on May 5th at 2:15 p.m. at the upcoming 2010 BIO International Convention. Hosted by the Biotechnology Industry Organization (BIO), the meeting will be held May 3-6, 2010 in Chicago, Ill. at McCormick Place.
|
|
|
|
|
|
|
|
|
|
|